DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Saccharin is an investigational drug.
There have been 8 clinical trials for Saccharin. The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2013.
The most common disease conditions in clinical trials are Hyperglycemia, Sinusitis, and Sclerosis. The leading clinical trial sponsors are National Cardiovascular Center Harapan Kita Hospital Indonesia, Osypka Germany, and Dalim BioTech Co., Ltd.
There is one US patent protecting this investigational drug and fifteen international patents.
Recent Clinical Trials for Saccharin
|Betadine Rinses for Chronic Rhinosinusitis Prospective Cohort Study||St. Paul's Hospital, Canada||Early Phase 1|
|Congenital CMV and Hearing Loss in Children up to 4 Years of Age: Treating With Valganciclovir Therapy||University of Alabama at Birmingham||Phase 2|
|Efficacy Study of Folic Acid Supplementation in Adolescent Epileptics||Maharashtra University of Health Sciences||Phase 3|
Top disease conditions for Saccharin
Top clinical trial sponsors for Saccharin
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Saccharin||Start Trial||Halogen-substituted heterocyclic compound||UBE INDUSTRIES, LTD. (Ube-Shi, JP)||Start Trial|
|Saccharin||Start Trial||Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors||Forma Therapeutics, Inc. (Watertown, MA)||Start Trial|
|Saccharin||Start Trial||Selective proton coupled folate transporter and folate receptor, and GARFTase inhibitor compounds and methods of using the same||Duquesne University of the Holy Spirit (Pittsburgh, PA)||Start Trial|
|Saccharin||Start Trial||Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same||Protalix Ltd. (Carmiel, IL)||Start Trial|
|Saccharin||Start Trial||Monomethylvaline compounds having phenylalanine side-chain modification at the C-terminus||Seattle Genetics, Inc. (Bothell, WA)||Start Trial|
|Saccharin||Start Trial||Composition for structural adhesive||JACRET (Le Thillay, FR)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|